GEHC geopolitical news & exposure
GEHC geopolitical news and exposure. GEHC appears in 170 Geopolitics Alpha notes. The newest is 01 Oct 2026, 15:29 UTC. Stored price-reaction rows cover 0 of those notes.
- Medtronic drug-coated balloon gets FDA breakthrough status
01 Oct 2026, 15:29 UTC
- Wall Street is closing out a strong quarter. Plus, Lilly's mixed obesity drug trial data
30 Sep 2026, 18:57 UTC
- Adding Lilly’s new drug to Zepbound helped people lose more weight — but there were more side effects
30 Sep 2026, 18:45 UTC
- FDA starts review of Roche’s multiple sclerosis pill
30 Sep 2026, 15:54 UTC
- Adding Lilly’s new drug to Zepbound helped people lose up to 23% of their weight. But there were more side effects.
30 Sep 2026, 14:32 UTC
- Eli Lilly says closely watched combo obesity regimen boosts weight loss in mid-stage trial
30 Sep 2026, 14:15 UTC
- Most powerful obesity drug yet: People lost up to 25% of weight in trial
29 Sep 2026, 22:30 UTC
- RFK Jr’s food policy priorities need more resources to implement, FDA nominee says
29 Sep 2026, 13:49 UTC
- RFK’s food policy priorities need more resources to implement, FDA nominee says
29 Sep 2026, 13:49 UTC
- AstraZeneca invests $2B in Summit, gaining ‘seat at the table’ for PD-1/VEGF drug push
29 Sep 2026, 12:49 UTC
- FDA Approves First Treatment for MCT8 Deficiency
28 Sep 2026, 21:43 UTC
- FDA intends to evaluate changes to the PMTA regulatory framework
28 Sep 2026, 21:00 UTC
- To keep drug prices high, pharma has been piling up the patents
28 Sep 2026, 19:53 UTC
- FDA issues draft guidance for surgical robots
28 Sep 2026, 15:34 UTC
- The Next Evolution of TLIF: Where Innovation Meets Clinical Evidence
28 Sep 2026, 09:00 UTC
- Generic Drug User Fee Amendments
25 Sep 2026, 23:34 UTC
- Can Trump ever be wrong? His pick to lead FDA refused to say.
25 Sep 2026, 23:00 UTC
- Non-Compliance Letters under 505B(d)(1) of the Federal Food, Drug, and Cosmetic Act
25 Sep 2026, 21:36 UTC
- What's New Related to Drugs
25 Sep 2026, 21:33 UTC
- Candy Power For Man may be harmful due to hidden ingredient
25 Sep 2026, 21:32 UTC
- Miracle Power of King Kong Honey may be harmful due to hidden ingredient
25 Sep 2026, 21:31 UTC
- Public Notification: Vital Honey contains hidden drug ingredient
25 Sep 2026, 21:27 UTC
- Novel Drug Approvals for 2026
25 Sep 2026, 21:24 UTC
- Notable Approvals | Drugs
25 Sep 2026, 18:48 UTC
- FDA Approves Third Treatment for Fibrodysplasia Ossificans Progressiva
25 Sep 2026, 18:46 UTC
- Novo pursues long-acting obesity drugs; Acadia slumps on Alzheimer’s data
25 Sep 2026, 13:21 UTC
- Novo is betting on its next chapter as Eli Lilly gains more ground in GLP-1s
25 Sep 2026, 11:00 UTC
- Pharma stock soars 150% on injectables deal with Wegovy maker Novo
25 Sep 2026, 09:58 UTC
- After capital-markets day flop, Novo strikes licensing deal that sends a Swedish company’s stock soaring
25 Sep 2026, 09:11 UTC
- RNAi drug specialist ADARx raises $446M IPO
25 Sep 2026, 00:36 UTC
- FDA nominee Overton parries vaccine questions at Senate hearing
24 Sep 2026, 20:46 UTC
- Merck reveals study success, and possible safety worries, for eye drug hopeful
24 Sep 2026, 15:34 UTC
- Oppenheimer Initiates Coverage of Pacira BioSciences with Outperform
24 Sep 2026, 07:36 UTC
- Oppenheimer Initiates Coverage of Amneal Pharmaceuticals at Outperform
24 Sep 2026, 00:33 UTC
- Federal Court Enters Consent Decree Against Gold Star Distribution, Inc. Following Persistent Insanitary Warehouse Conditions
23 Sep 2026, 19:50 UTC
- Roche, Ionis RNA drug scores in kidney disease study
23 Sep 2026, 16:21 UTC
- 9 pharma leaders sound ‘alarm bells’ on biotech’s decline in Europe
23 Sep 2026, 15:13 UTC
- This test screens for 50 cancers — but whether Medicare and other health insurers will cover it hinges on FDA approval
23 Sep 2026, 12:58 UTC
- FDA advisers are reviewing a multicancer-detection test. Medicare coverage could follow.
23 Sep 2026, 12:39 UTC
- Amgen reports a Phase 3 win with Sjögren’s drug candidate
22 Sep 2026, 18:31 UTC